ABSTRACT
In the era of COVID pandemic, it is highly desirable to improve body's immune responses. Many of the diseases including COVID impact the immune system and make it defenseless. There is a growing interest of herbal medicine around the world owing to effective pharmacological actions attributed by its unique phytocompounds. Majority of the immunomodulatory drugs including both immunosuppressor and immuno-stimulators are synthetic organic compounds having side effects. Therefore, there is a growing interest to use plant-based products to regulate immune responses. The present chapter deals with the recognition of members of the family Solanaceae for their use as potential immunomodulators. There are quite a few reports of active phytocompounds isolated from different solanaceous plants that have a myriad of medicinal properties. Various phytochemicals such as phenolic compounds, flavonoids, alkaloids, terpenes, lactones, and glycosides have been shown to have various therapeutic effects on human body owing to their ability to influence body's immune system. The present chapter will give a comprehensive overview of plant-based therapeutics of solanaceous plants including withanolides isolated from Withania somnifera and Physalis sps, capsaicinoids isolated from Capsicum, and lycopene from tomato. Solanaceae is one of the superfamily having huge repertoire of plants belonging to major food crops utilized throughout the world (tomato, potato, capsicum etc.) as well as in medicine category. Besides several members of the Solanaceae family such as Physalis sps, Atropa sps, Datura stramonium, and Solanum xanthocarpum have potential phytomolecules belonging to alkaloids, terpenoids, and steroid category, which are recognized as medicines. This chapter will also give a critical overview of the possibilities, facts, and prospects of the use of members of Solanaceae family as potential future immunomodulatory drugs. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022.
ABSTRACT
Background Coronavirus disease 2019 (COVID-19) presents clinically a variety of pathological and clinical organ dysfunctions, ranging in severity from asymptomatic to fatal. The care and monitoring of COVID-19 patients may benefit from the use of biochemical and hematological markers. Objective To observe the alteration of serum biochemical and hematological parameters in COVID-19 positive patients, attending a Tertiary Care Hospital. Method A descriptive cross-sectional study was conducted on all COVID-19 positive patients attending Nobel Medical College Teaching Hospital, Biratnagar, Nepal from 15th December 2021 to 15th February 2022. The test results of different serum biochemical and hematological parameters done for these patients were recorded in clinical laboratory services and obtained retrospectively for the analysis. The data were entered in MS excel and analyzed by SPSS version 20. Result Out of 1537 COVID-11699 declared positive patients, 712 (46.32%) were male and 825 (53.68%) female. Mean age of COVID positive patients was 40.03±20.08 years. The level of serum SGOT, SGPT, ALP and GGT was significantly elevated in 39.9%, 42.8%, 32.3% and 47.2% of COVID positive patients respectively. Blood Urea, creatinine, uric acid and sugar level were significantly elevated in 63%, 56.1%, 33.1% and 47.6% patients respectively. The serum level of LDH, D-dimer, CRP and procalcitonin (PCT) were significantly increased in 52.1%, 75.9%, 71.6% and 61.2% of patients respectively. The serum value of total cholesterol, triglyceride, HDL and LDL were significantly lowered in 52.2%, 43.8%, 70.1% and 60.3% of patients respectively. RBC concentration and level of hemoglobin was reduced in 56.6% and 53.6% of COVID positive patients respectively whereas total leukocyte count was elevated in 80.7% with increase in neutrophil in 87.9% and decrease in lymphocyte in 79.4%. Conclusion A portion of COVID-19 positive patients showed drastically altered test results for various serum biochemical and hematological markers, although many of them had normal findings.
Subject(s)
COVID-19 , Humans , Male , Female , Young Adult , Adult , Middle Aged , SARS-CoV-2 , Tertiary Care Centers , Retrospective Studies , Cross-Sectional StudiesABSTRACT
Background Coronavirus disease 2019 (COVID-19) presents clinically a variety of pathological and clinical organ dysfunctions, ranging in severity from asymptomatic to fatal. The care and monitoring of COVID-19 patients may benefit from the use of biochemical and hematological markers. Objective To observe the alteration of serum biochemical and hematological parameters in COVID-19 positive patients, attending a Tertiary Care Hospital. Method A descriptive cross-sectional study was conducted on all COVID-19 positive patients attending Nobel Medical College Teaching Hospital, Biratnagar, Nepal from 15th December 2021 to 15th February 2022. The test results of different serum biochemical and hematological parameters done for these patients were recorded in clinical laboratory services and obtained retrospectively for the analysis. The data were entered in MS excel and analyzed by SPSS version 20. Result Out of 1537 COVID-11699 declared positive patients, 712 (46.32%) were male and 825 (53.68%) female. Mean age of COVID positive patients was 40.03+/-20.08 years. The level of serum SGOT, SGPT, ALP and GGT was significantly elevated in 39.9%, 42.8%, 32.3% and 47.2% of COVID positive patients respectively. Blood Urea, creatinine, uric acid and sugar level were significantly elevated in 63%, 56.1%, 33.1% and 47.6% patients respectively. The serum level of LDH, D-dimer, CRP and procalcitonin (PCT) were significantly increased in 52.1%, 75.9%, 71.6% and 61.2% of patients respectively. The serum value of total cholesterol, triglyceride, HDL and LDL were significantly lowered in 52.2%, 43.8%, 70.1% and 60.3% of patients respectively. RBC concentration and level of hemoglobin was reduced in 56.6% and 53.6% of COVID positive patients respectively whereas total leukocyte count was elevated in 80.7% with increase in neutrophil in 87.9% and decrease in lymphocyte in 79.4%. Conclusion A portion of COVID-19 positive patients showed drastically altered test results for various serum biochemical and hematological markers, although many of them had normal findings. Copyright © 2022, Kathmandu University. All rights reserved.
ABSTRACT
The COVID-19 pandemic resulted in changed emission regimes all over the world. India also imposed complete lockdown on all modes of travel and industrial activities for about 2 months from 25-March-2020 and later unlocked these activities in a phased manner. Here, we study signatures of emissions changes on levels of atmospheric trace gases and aerosols contributing to air pollution over multiple sites in India’s capital Delhi covering various lockdown and unlock phases using satellite data and in-situ observations. The resulting changes in the levels of these species were compared with respect to their average of 2015–2019 to attribute for year to year and seasonal changes. A clear impact of lockdown was observed for AOD, PM, NO2, CO, and SO2 as a result of emission changes, while changed precursor levels led to a change in O3 chemical regimes impacting its concentrations. A detailed analysis of FLEXPART trajectories revealed increased PM levels over Delhi in north-westerly air masses sourced to Punjab region all the way up to Pakistan. Changes in aerosols and NO2 were not only restricted to the surface but transcended the total tropospheric column. The maximum decrease in PM, NO2, CO, and SO2 was observed during the month of total lockdown in April. The lockdown impact varied with species e.g., PM10 and PM2.5 as well as locations even within the periphery of Delhi. While surface level aerosols and NO2 showed significant and almost similar changes, AOD showed much lower decrease than tropospheric column NO2. © Copyright © 2021 Mallik, Gadhavi, Lal, Yadav, Boopathy and Das.
ABSTRACT
Background: Covid-19 disease is caused by novel coronavirus known as SARS CoV 2. Coronaviruses are known to cause disease in humans which can be a common cold or a serious pneumonia. SARS Cov 2 is a new variant of coronavirus which was never reported in humans before detection of cluster of cases of pneumonia in Wuhan on 31st December, 2019.Objective: The study was conducted with the objective to find out clinico-epidemiological profiles of early Covid-19 patients in state of Haryana, India and to find out knowledge about covid appropriate behaviors among covid 19 patients. Methods: All the covid-19 cases in the five districts of Haryana were enumerated from March 2020 to May 2020. These Covid-19 cases were contacted telephonically and those who gave their consent to participate in the study were asked to fill interview schedule. Observations: There were 356 covid cases reported in five districts attached to PGIMS, Rohtak. Out of total,254 subjects participated in the study, there were 60.6 % males and 39.4% females who participated in the study. Blood groups of all the participants were also enquired and it was observed that B +ve was most common (19.7%) blood group followed by A+ve (16.5%) and O +ve (15.7%). Conclusion: It can be concluded by the study that majority of the subjects were males, overweight and blood group A & B were the most common blood groups. It was observed that 75.2 % participants were aware about the use of mask, social distancing, hand hygiene and cough etiquettes.